Autosomal recessive primary microcephaly (MCPH) is a disorder of neurodevelopment resulting in a small brain 1,2 . We identified WDR62 as the second most common cause of MCPH after finding homozygous missense and frame-shifting mutations in seven MCPH families. In human cell lines, we found that WDR62 is a spindle pole protein, as are ASPM and STIL, the MCPH7 and MCHP7 proteins 3-5 . Mutant WDR62 proteins failed to localize to the mitotic spindle pole. In human and mouse embryonic brain, we found that WDR62 expression was restricted to neural precursors undergoing mitosis. These data lend support to the hypothesis that the exquisite control of the cleavage furrow orientation in mammalian neural precursor cell mitosis, controlled in great part by the centrosomes and spindle poles, is critical both in causing MCPH when perturbed and, when modulated, generating the evolutionarily enlarged human brain 6-9 .
to right, chromosome 19, shown as a G-banded cartoon; the initial linkage region defined by homozygous microsatellite markers; the final minimal linkage region defined by homozygous SNPs; the region subject to genome capture (slightly larger and overlapping the minimal linkage region); and WDR62 shown as an arrow pointing from 5′ to 3′. Critical defining heterozygous markers are shown that bound each defined region. (b) WDR62 is shown from 5′ to 3′, from left to right. Exons are shown to scale and introns are shown as an artificial fixed interval for clarity. The position of each homozygous mutation is shown. The lengths of the gene and protein are given. Below the gene, the WDR62 protein is shown with each WD repeat detected by PFAM, shown as a filled in triangle. The position that each DNA mutation affects the WDR62 protein is shown beneath, with indication of the resultant amino acid or peptide change. For the c.4241dupT mutation (resulting in the p.Leu1414LeufsX41 alteration), an explanatory cartoon is shown at the bottom of the figure. This mutation causes a frame shift in the penultimate exon of WDR62, which does not give rise to a new stop codon until the terminal exon. After the frame shift, 17 novel amino acids were found, and those amino acids at the start of the frame shift, at the splice sites and at the position of the new premature stop codon are shown. In each of these families, all affected individuals fulfilled the diagnostic criteria for MCPH and shared only one concordant homozygous region 10, 15 . As this genomic region was sequenced and ordered, polymorphic microsatellite markers were used to iteratively define the meiotic crossovers in each family. Final refinement was achieved through analysis of SNPs in a critical affected individual from each family using the Affymetrix GeneChip Human Mapping 250K Nsp Array. This led to the delineation of a 3.2 cM and 2.6 Mb region. Candidate gene sequencing within this region, based on selection for embryonic brain expression and/or neurogenic, centrosome, spindle pole and/or mitotic function, failed to identify MCPH2. We concluded that MCPH2 was either uncharacterized or that the mutational mechanism leading to disease was unusual. To address both of these possibilities, we used genome capture followed by massive parallel sequencing in one affected individual from each of our two MCPH2-mapping families 16 . We searched for a gene that contained a potentially pathogenic homozygous mutation in both families. This process identified only one gene, WDR62, with the homozygous missense mutation c.1313G>A and a homozygous one-base-pair insertion, c.4241dupT (Fig. 1 , Table 1 and Supplementary Table 1) . We then screened WDR62 in five further consanguineous families with an MCPH phenotype that displayed linkage to the MCPH2 locus and for which mutations in all other MCPH genes had been eliminated (Online Methods). We found four further homozygous mutations: three missense mutations (one of which occurred in two families) and one protein-truncating mutation (Fig. 1b, Table 1 and Supplementary  Fig. 1 ). All WDR62 mutations segregated as expected for a recessive pathogenic change, were not recorded in genomic databases and were not present in ethnically matched controls (c.1531G>A was found in 1 out of 284 control chromosomes; Table 1 ).
WDR62 is a gene with 32 exons and a single CpG island and polyadenylation signal (Fig. 1b) . High expression has been recorded in lymphocytes and testes, but it has not previously been reported in embryonic or adult brain. There are two alternative WDR62 transcripts that have been recorded in human: exon 27 contains an in-frame, intra-exonic alternative splice acceptor site resulting in the exclusion of the first 12 nucleotides. WDR62 consists of 1,523 amino acids, contains at least 15 WD repeats, but has no ascribed functions either in organisms or in cells (Fig. 1b) .
Four of the six WDR62 mutations are missense (Table 1 and Fig. 1b) . The mutation c.4241dupT is expected to give rise to a stable RNA with a frame shifting insertion in the penultimate exon, resulting in a new premature stop codon in the final exon, yielding a C-terminal deletion of 109 amino acids in a region that contains neither predicted protein domains nor post-translational modification sites (Fig. 1b) . Only the mutation c.3936dupC (resulting in the p.Val1314ArgfsX18 alteration) is expected to cause nonsense-mediated decay by forming a new premature stop codon in exon 30 and can be regarded as a probable null mutation.
None of the missense mutations or c.4241dupT is predicted to alter any of the WD repeat domains of WDR62. However, three of the missense mutations (resulting in p.Val65Met, p.Arg438His and p.Asp511Asn) alter evolutionarily highly conserved amino acids (including in all seven Drosophila species) (Supplementary Fig. 2 ). WDR62 has a mammalian homolog, MAPKBP1, in which again the three amino acids affected by the missense mutations are conserved. However, the alteration p.Ala1078Thr occurs in the C terminus of WDR62, and this region has diverged from the Drosophila ortholog of WDR62 and the human homolog MAPKBP1. This is not a highly conserved residue, as the wild-type amino acid The two primary mapping families. The mutation nomenclature for the cDNA and the protein are given, as well as the mutation type and in which exon the mutation occurs. The pedigree designation is given. For each family, the number of affected individuals seen and included in the study is given as well as the number of affected sibships in each pedigree. Finally, the details and results of control panel screen for each mutation is given. WT, wild type.
l e t t e r s is restricted to primates. We regard this mutation as one of unknown pathogenicity (Supplementary Fig. 2) . Notably, mutations in the multiple WD repeat-containing BRWD3 cause X-linked mental retardation associated with macrocephaly 17 . WDR62 was reported to be phosphorylated during mitosis in one study but not in a subsequent, more detailed study 18, 19 . We therefore determined the subcellular distribution of WDR62 by immunocytochemistry and confocal microscopy in the following three human cell lines: HeLa (cervical cancer derived), HEK293 (embryonic renal derived) and lymphoblastoid (from B lymphocytes). All cells showed the same pattern (Fig. 2) . In interphase cells, WDR62 had weak, diffuse cytoplasmic expression and was not nuclear. During mitosis, WDR62 accumulated strongly at the spindle poles but was not present at the midbody in cytokinesis. The expression pattern of WDR62 we found is identical to that of ASPM, another MCPH protein expressed at and able to focus the spindle poles in neural precursor cells (Supplementary Fig. 3 and refs. 8,20) .
We investigated the pathogenicity of the missense mutations found in our two largest MCPH2 families, c.1313G>A and c.4241dupT. We engineered a gene construct of full length wild-type WDR62 with a C-terminal GFP fusion. We transfected cells and showed that this construct displayed diffuse interphase expression followed by spindle pole accumulation during mitosis (Fig. 3) . Thus, the construct mimicked the wild-type subcellular localization pattern of WDR62. We then introduced the c.1313G>A missense mutation and the c.4241dupT frame shift mutation into a WDR62-GFP construct. These mutation constructs both led to expression of the fusion protein WDR62-GFP in the cytoplasm but not at the spindle poles during mitosis ( Fig. 3 and Supplementary Fig. 4 ). This suggests that the c.1313G>A point mutation and the frame shift mutation c.4241dupT are both capable of independently abrogating the accumulation of WDR62 at the spindle pole and suggests that the common disease mechanism for MCPH2 microcephaly might be an absence of WDR62 at the spindle pole of dividing cells. These results do not allow us to determine if the mutant proteins have lost essential spindle targeting domains or if they are misfolded and become rapidly degraded 21 .
It is hypothesized that MCPH is caused by a mitotic deficiency in the neural precursors in embryonic brain. Thus, we determined the tissue expression pattern of WDR62 in mouse and human embryonic brain using immunohistochemistry and confocal microscopy. We examined embryonic mouse brain at embryonic day (E) 11, E13 and E15 (ref. 22) . These time points span the start of the generation of neurons destined for the cerebral cortex through to the establishment of the cortical plate 23, 24 . We saw significant results in the neuroepithelium of the future cerebral cortex (Fig. 4) . Firstly, Wdr62 expression in the neuroepithelium was found exclusively in apical precursors undergoing mitosis at the apical-ventricular surface. Apical precursors are the only cells recorded to undergo mitosis in the apical region of the neuroepithelium and can be identified by Nestin expression, the morphology of cellular DNA as a 'metaphase plate' , and by having two centrosomes opposed to each other on either side of the 'metaphase plate' . Secondly, intermediate neural precursors (also called basal precursors 25, 26 ) found in the sub-ventricular zone of the embryonic brain also expressed Wdr62 exclusively during mitosis. 
l e t t e r s
Tissue processing does not allow the preservation of microtubules and, hence, mitotic spindle visualization; therefore we were unable to show that, as in cell lines, Wdr62 was a spindle pole protein in neural precursor cells in vivo. Magnified views of mouse apical neural progenitors highlight Wdr62 expression in mitotic cells (Fig. 4b) . We then assessed the expression of WDR62 in human embryonic brain at gestation stage CS22, which is equivalent to mouse neurogenesis at stage E13 (ref. 27) . By staining cells with γ-tubulin along with a WDR62 antibody, we saw the same pattern of expression as in mouse, with expression of WDR62 only in mitotic neural precursor cells ( Fig. 4c and Supplementary Fig. 5 ).
We then investigated the developing cortical plate. We found WDR62 expression in newborn neurons and in the outermost layer of neurons that had just migrated to the cortical plate (Fig. 5a) . The subcellular localization of WDR62 in these neurons was nuclear (WDR62 has no canonical basic amino acid nuclear-localization domain) and was not at spindle poles or centrosomes, as seen in neural precursors (Fig. 5a,b) . A recent study reported WDR62 mutations in individuals with severe brain malformations and found interphase nuclear localization of WDR62 (ref. 28 ). The subcellular localization data agree for newly migrated cortical neurons but not for other cells where our and previously published data all strongly support a spindle pole localization of WDR62 in dividing cells 18, 19 .
We had only two brain scans available from study families (Fig. 5c) ; these scans were from a child with the missense mutation c.1313G>A, which showed a simplified gyral pattern, and from a child with a null mutation c.3936dupC, which also showed the simplified gyral pattern but also that the cerebral cortex was thickened. The latter individual had a substantially more severe clinical course (Online Methods). This expression and clinical data together suggest that WDR62 may also have a role in cortical lamination. It is therefore possible that missense mutations leading to WDR62 proteins that cannot be targeted to spindle poles cause a deficiency of neurogenesis resulting in primary microcephaly, but that nonsense mutations leading to a complete lack of WDR62 production cause a more severe microcephaly phenotype because of the addition of a cerebral cortex lamination defect. Future studies should determine if this conjecture is correct.
In conclusion, WDR62 is the cause of the second commonest form of MCPH and encodes a spindle pole protein that is expressed in neuronal precursor cells undergoing mitosis in the mammalian embryonic neuroepithelium. ASPM, the MCPH5 protein, is also a spindle pole protein and in Aspm-deficient mice, increased numbers of apical precursor cells undergo asymmetric (neuron generating) rather than symmetric (neural precursor generating) cell division 6 . In the human brain, symmetric rather than asymmetric divisions are initially needed to generate a large pool of neural precursors. This observation may explain the reduced neuron numbers seen in primary microcephaly. That WDR62, ASPM and STIL are all spindle pole proteins suggests the unique importance of focused spindle poles in neural progenitor cell division. The spindle poles are attached to the mature centrosomes in these cells and together control the position of the central spindle and hence the direction of the last stage of the cytokinesis cleavage furrow 9, 29, 30 . The furrow has to exactly bisect a small apical-membrane fate-determining domain (the cadherin hole) to ensure a symmetric division and production of two daughter cell neural precursors 8, 31, 32 . The cadherin hole diminishes in size as neurogenesis progresses from 2% to 1% of the total cell surface 30 . Once a cell fails to inherit part of a cadherin hole, its fate changes and it differentiates into a neuron, becomes post-mitotic and migrates out of the neuroepithelium. Our data suggest that WDR62 is a key protein in enabling spindle poles to position the cytokinetic furrow and prolong neural precursor generation, a process that is uniquely vital to human cerebral cortex growth.
URLs. Human genome browser, http://genome.ucsc.edu/; PFAM for protein domain recognition, http://pfam.sanger.ac.uk/search?tab=searchSe quenceBlock; BLAST for nucleotide and protein alignment and similarity assessment, http://blast.ncbi.nlm.nih.gov/Blast.cgi; MRC-Wellcome Trust Human Developmental Biology Resource, http://www.hdbr.org/.
MeTHoDS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/naturegenetics/.
Note: Supplementary information is available on the Nature Genetics website.
